3.85 USD

Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/21/2024 7:33:26 PM)
Exchange closed, opens in 13 hours 56 minutes
1.32 USD (1.32%)
-4.47 USD (-4.47%)
-6.33 USD (-6.33%)
-20.94 USD (-20.94%)
-47.90 USD (-47.90%)
-51.02 USD (-51.02%)
-56.35 USD (-56.35%)
-45.77 USD (-45.77%)

About OraSure Technologies

Market Capitalization 287.19M

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.

Headquarters (address)

220 East First Street

Bethlehem 18015 PA

United States

Phone610 882 1820
Websitehttps://www.orasure.com
Employees638
SectorHealthcare
IndustryMedical Instruments & Supplies
TickerOSUR
ExchangeNASDAQ Stock Exchange
CurrencyUSD
52 week range3.72 - 8.45
Market Capitalization287.19M
Dividend yield forward167.98 %
Dividend yield forward United States (ID:6, base:1863) 4.21 %
P/E trailing25.67
P/E forward-24.06
Price/Sale1.28
Price/Book0.675
Beta0.046
EPS0.150
EPS United States (ID:6, base:3395) 24.30

Forward Annual Dividend Yield

Forward Annual Dividend Yield: OraSure Technologies has raised their dividend 167.98 years in a row. This is below the 41124.611300 year average in the 'Medical Instruments & Supplies' industry

Forward Annual Dividend Yield

Forward Annual Dividend Yield: OraSure Technologies has raised their dividend 167.98 years in a row. This is below the 41124.611300 year average in the 'Medical Instruments & Supplies' industry

CleverShares.com|
2024 ©

1.0.9089.36765